Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This term refers to the unintended silencing of various human messenger RNAs (mRNAs) by a short hairpin RNA (shRNA) designed to target the SETD8 gene. SETD8, also known as KMT5A, is a histone methyltransferase that specifically monomethylates histone H4 at lysine 20 (H4K20me1), a modification essential for chromatin condensation, DNA replication, and DNA damage repair (Nishioka et al., 2002; Rice et al., 2002). Off-target effects arise when the shRNA guide strand binds to non-target mRNAs via partial sequence complementarity, primarily through the 2-7 nucleotide "seed" region in the 3' untranslated region (UTR) of the transcript (Lewis et al., 2003; Birmingham et al., 2006). These interactions can lead to mRNA degradation or translational inhibition, resulting in phenotypic changes that are not caused by the loss of SETD8 itself (Jackson et al., 2003). In drug discovery and functional genomics, these off-targets are a significant source of experimental noise and potential toxicity for RNAi-based therapeutics. Identifying and mitigating these effects is crucial for ensuring the specificity of gene knockdown and the safety of therapeutic interventions.
RNA interference-mediated degradation or translational inhibition of non-target mRNAs via partial sequence complementarity (Jackson et al., 2003; Birmingham et al., 2006).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other human mRNAs with partial complementarity to the SETD8 shRNA guide strand.